USPTO serial 88209977
ALL ABOUT BLEEDING
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- FALK, ERIN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALL ABOUT BLEEDING?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
King of Prussia, PA
King of Prussia, PA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 THOMAS JEFFERSON ST. NW, SUITE 400WASHINGTON, DC 20007UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 016 | Printed materials, namely, journals, newsletters, articles and case studies featuring blood related diseases, biopharmaceuticals and biotherapies; Printed publications, namely, brochures, booklets, newsletters, articles, case studies, and teaching materials in the field of blood related diseases; printed educational materials in the field of blood related diseases | ACTIVE | — |
| 035 | Promoting public awareness of Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; promoting public awareness of Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals by means of public advocacy and patient and caregiver public advocacy; public policy research services concerning policy initiatives for Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; Promoting the donation of blood, volunteer services, and financial resources in the field of blood donations by means of arranging and conducting incentive reward programs | ACTIVE | — |
| 041 | Healthcare education services, namely, providing educational and awareness educational training programs for patients, caregivers and/or healthcare professionals concerning Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; organizing, planning and conducting educational conventions and educational meetings related to Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals | ACTIVE | — |
| 042 | Medical and scientific research in the field of health, wellness, and blood conditions | ACTIVE | — |
| 044 | Healthcare and healthcare information services, namely, providing healthcare information concerning Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; Providing a website featuring information in the field of health, blood, bleeding conditions, and corresponding treatments; Healthcare and healthcare information services, namely, providing healthcare information concerning hemophilia, platelet dysfunction, perioperative bleeding, rare bleeding disorders, fibrinogen deficiency, anticoagulant reversal, and other blood related diseases, treatment and impacts on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing healthcare information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by bleeding conditions; Providing a website featuring healthcare information in the field of the diagnosis and treatment of blood conditions; Providing links to the web sites of others featuring information about the diagnosis and treatment of blood conditions and treatments | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CSL Behring L.L.C.
- Other trademarks owned by CSL Behring L.L.C.
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ALL ABOUT BLEEDING
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 23, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 23, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 21, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 20, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| May 20, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 17, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| May 17, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 20, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 18, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Nov 18, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 18, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 19, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 17, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 17, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 17, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 19, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 17, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 17, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 17, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 19, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 15, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 15, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 15, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 17, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 22, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 22, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 2, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 13, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 13, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 13, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 13, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 13, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 13, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 13, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 9, 2019 | ALIE | ASSIGNED TO LIE | — |
| Sep 3, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 4, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 1, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 18, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Dec 17, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 3, 2018 | NWAP | NEW APPLICATION ENTERED | — |